Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
51.84
+1.26 (2.49%)
Feb 21, 2025, 4:00 PM EST - Market closed
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $3.95 billion as of February 21, 2025. Its market cap has increased by 299.39% in one year.
Market Cap
3.95B
Enterprise Value
3.20B
1-Year Change
299.39%
Ranking
Category
Stock Price
$51.84
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $3.95B, an increase of 697.55%. That is a compound annual growth rate of 44.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.67B |
| UnitedHealth Group | 429.45B |
| Johnson & Johnson | 391.17B |
| Novo Nordisk | 370.84B |
| AbbVie | 356.64B |
| Abbott Laboratories | 234.60B |
| AstraZeneca | 229.50B |
| Merck & Co. | 225.69B |